{
    "clinical_study": {
        "@rank": "107538", 
        "acronym": "SVMKK", 
        "arm_group": [
            {
                "arm_group_label": "Sindhuvallathy mezhugu", 
                "arm_group_type": "Experimental", 
                "description": "Sindhuvallathy mezhugu (SVM) 500 mg Twice daily per Oral 45 days duration"
            }, 
            {
                "arm_group_label": "Kalladaippu Kudineer", 
                "arm_group_type": "Experimental", 
                "description": "Kalladaippu Kudineer (KK) 130 ml decoction Twice daily Per oral 45 days Duration"
            }, 
            {
                "arm_group_label": "Sindhuvallathy  + Kalladaippu Kudineer", 
                "arm_group_type": "Experimental", 
                "description": "Sindhuvallathy mezhu -500 mg capsules twice daily + Kalladaippu kudineer  -130 ml decoction twice daily-per oral for 45 days."
            }
        ], 
        "brief_summary": {
            "textblock": "This study is a non randomized non comparative study with two Siddha formulations\n      Sindhuvallathy Mezhugu and Kalladaippu Kudineer are available in Siddha classical texts\n      existing for longer period. But there is no scientific data is documented about these\n      formulations. This study aimed to evaluate the efficacy of the study drugs for urolithiasis.\n       After the preliminary drug standardization the clinical  study is Started at The National\n      Institute of Siddha  Tambaram. The primary outcome measure is either the Expulsion of stones\n      or Changes in the number and size of the stones with 45 days drug treatment."
        }, 
        "brief_title": "A Clinical Study to Evaluate the Efficacy of Two Siddha Drugs Sindhuvallathy Mezhugu and Kalladaippu Kudineer for Kidney Stones", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Urolithiasis", 
        "condition_browse": {
            "mesh_term": [
                "Kidney Calculi", 
                "Urolithiasis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Objectives:\n\n      Primary Objectives. To assess the efficacy of sindhu vallathy mezhugu and Kalladaippu\n      kudineer in Urolithiasis.\n\n      Secondary objectives\n\n        1. To standardize the study drugs.\n\n        2. To observe the adverse effects if any\n\n      Methods of proposed research:\n\n      The consists of two segments Part - A.   Non- clinical studies -standardisation of the study\n      drugs. Part  - B.   Clinical studies.\n\n      Study drugs\n\n        1. Sindhu Vallathy mezhugu will be prepared as per the literature Agasthiar vaidhya\n           vallathy 600.\n\n        2. Kalldaippu Kudineer  will be adapted from Athmaraktchamirtham Ennum Vaidhya\n           Sarasangeeragam, 1968,page  349, 2.Siddha formulary of India part-II"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age> 18 years\n\n          -  both gender\n\n          -  diagnosed ultrasonographically/radiographically with visible calculi of >5mm\n\n          -  with or without clinical symptoms .\n\n        Exclusion Criteria:\n\n          -  Patients with severe pain and not responding to pain killers\n\n          -  Bilateral Calculi obstruction requiring immediate surgery,\n\n          -  Existing renal failure,\n\n          -  Pregnant and lactating women,\n\n          -  Age<18 years,\n\n          -  known hepatic and cardiac diseases,\n\n          -  Subjects those who are not willing to give informed consent\n\n          -  Women those who are planning for pregnancy ."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01847963", 
            "org_study_id": "MGR-10-KR- 1301", 
            "secondary_id": "BCR - 2043"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Sindhuvallathy mezhugu", 
                    "Sindhuvallathy  + Kalladaippu Kudineer"
                ], 
                "description": "500 mg capsules per oral twice daily for 45 days  a Siddha classical literature preparation", 
                "intervention_name": "Sindhuvallathy mezhugu ( SVM)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Kalladaippu Kudineer", 
                    "Sindhuvallathy  + Kalladaippu Kudineer"
                ], 
                "description": "130 ml decoction twice daily-per oral for 45 days, a Siddha classical literature preparation", 
                "intervention_name": "Kalladaippu Kudineer (KK) -", 
                "intervention_type": "Drug", 
                "other_name": "Sirupeelai kudineer"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Urolithiasis", 
            "Kalladaippu Kudineer", 
            "Siddha", 
            "Sindhuvallathy", 
            "Kidney stones"
        ], 
        "lastchanged_date": "May 2, 2013", 
        "location": {
            "contact": {
                "email": "herbsiddha@rediffmail.com", 
                "last_name": "Dr. K Rajalakshmi"
            }, 
            "contact_backup": {
                "email": "loga.nis@yahoo.com", 
                "last_name": "Dr, Logamanian, Ph.D", 
                "phone": "9444362069"
            }, 
            "facility": {
                "address": {
                    "city": "Chennai", 
                    "country": "India", 
                    "state": "Tamilnadu", 
                    "zip": "600 024"
                }, 
                "name": "National Institute of Siddha"
            }, 
            "investigator": [
                {
                    "last_name": "Dr. K Rajalakshmi, M.D(s)", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Dr. M Logamanian, M.D(s)", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "3", 
        "official_title": "Standardization and Clinical Evaluation of Siddha Formulations for Urolithiasis /Kalladaippu.", 
        "overall_contact": {
            "email": "herbsiddha@rediffmail.com", 
            "last_name": "Dr. K. Rajalakshmi, M.D(s)", 
            "phone": "98409 61455"
        }, 
        "overall_official": {
            "affiliation": "The Tamilnadu Dr. MGR. Medical University", 
            "last_name": "Dr. K Rajalakshmi, M.D (s)", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The recruited subjects will be assessed for their  parameters from base line and 15th day 30th day and 45th day of drug treatment. It will be measured either the expulsion of stones and/or reduction in number and size of stones from the  baseline. The Ultra sound abdomen or X-ray will be done on 0 day and 45th day only.", 
            "measure": "Expulsion of stones or Reduction in the number and size of the stones.", 
            "safety_issue": "Yes", 
            "time_frame": "0,15,30,45  days post drug treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01847963"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Tamil Nadu Dr.M.G.R.Medical University", 
            "investigator_full_name": "Dr. K. Rajalakshmi", 
            "investigator_title": "Assistant professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "All the clinical parameters and Investigatory parameters will be assessed from baseline and in every follow up visit till 45 days.", 
                "measure": "Prevention of stone forming factors within the study period.", 
                "safety_issue": "Yes", 
                "time_frame": "0,15th ,30th  and 45th day"
            }, 
            {
                "description": "Based on the reduction in the clinical symptoms", 
                "measure": "Reduction in pain and symptom score", 
                "safety_issue": "No", 
                "time_frame": "0  15  30 45 days"
            }, 
            {
                "description": "Changes in other laboratory parameters lipid profile renal profile urinary parameters etc will be measured", 
                "measure": "Changes in other investigations", 
                "safety_issue": "Yes", 
                "time_frame": "0 15th 30th 45th days"
            }
        ], 
        "source": "Tamil Nadu Dr.M.G.R.Medical University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University grants commission", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Tamilnadu Dr MGR Mecical University research council", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Tamil Nadu Dr.M.G.R.Medical University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}